All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells. (Q53222927)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Yi-Hui Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Wen-Tai Chiu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Tzu-Yu Weng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yu-Fang Huang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Cheng-Yang Chou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

5 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

498-507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

γ-Secretase Inhibitor, DAPT Inhibits Self-renewal and Stemness Maintenance of Ovarian Cancer Stem-like Cells In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Targeting Notch to target cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Effect of all-trans retinoic acid on the differentiation of U87 glioma stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Differentiation therapy exerts antitumor effects on stem-like glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Retinoid signaling regulates breast cancer stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPbeta interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Ovarian cancer stem cells: a new target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Forkhead box M1 transcription factor: a novel target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

FOXM1: From cancer initiation to progression and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Induction of human epithelial stem/progenitor expansion by FOXM1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

FoxM1 and Wnt/β-catenin signaling in glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

The role of human aldehyde dehydrogenase in normal and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

Retinoids, Retinoic Acid Receptors, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV018

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGV018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742746%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference